ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02437890
Brief Title: A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

First Submitted : April 29, 2015
First Submitted that Met QC Criteria : May 7, 2015
First Posted : May 8, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 26, 2018
Last Update Posted : February 27, 2018